Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities
Magdalena Rašková, Lukáš Lacina, Zdeněk Kejík, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3698-3698
Open Access | Times Cited: 121
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
Multiple myeloma: signaling pathways and targeted therapy
Qizhong Lu, Donghui Yang, Hexian Li, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 17
Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
Robert Roskoski
Pharmacological Research (2022) Vol. 183, pp. 106362-106362
Closed Access | Times Cited: 60
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia
John Mascarenhas
Expert Review of Hematology (2022) Vol. 15, Iss. 8, pp. 671-684
Closed Access | Times Cited: 42
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
Mateusz Kciuk, Manzar Alam, Nemat Ali, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5246-5246
Open Access | Times Cited: 40
NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation
Peng Zhang, Liang Chen, Fenfang Zhou, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 27
G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition
Yungang Wang, Hongli Liu, Zhe Zhang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006166-e006166
Open Access | Times Cited: 27
The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure
Ying Fu, Xiang Yu, Ying Wang, et al.
Theranostics (2023) Vol. 13, Iss. 9, pp. 2757-2773
Open Access | Times Cited: 26
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
Hyun-Jung Park, S.-H. Lee, Jaehun Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13764-13764
Open Access | Times Cited: 25
Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations
Rupali Kohal, Priya Bisht, Ghanshyam Das Gupta, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107095-107095
Closed Access | Times Cited: 14
Crosstalk between CAFs and tumour cells in head and neck cancer
Xinyang Li, Celia González-Maroto, Mahvash Tavassoli
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 10
Revealing the association between East Asian oral microbiome and colorectal cancer through Mendelian randomization and multi-omics analysis
Yuheng Gu, Lai Jiang, 敏之 清水, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics
Manish Kumar
(2025)
Closed Access | Times Cited: 1
Effects of hypoxia on the heart of the juvenile four-finger threadfin (Eleutheronema tetradactylum) based on physiological indicators and transcriptome analysis
Yi Lu, Eric Amenyogbe, Ye Yang, et al.
Frontiers in Marine Science (2025) Vol. 12
Open Access | Times Cited: 1
JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications
Bilal Rah, Nada Mazen Farhat, Mawieh Hamad, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3147-3157
Closed Access | Times Cited: 18
Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation
Tao Liu, Xiang Wan, Zhizhuang Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 16
Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells
Xinru Wang, Rumeng Ding, Zhe Fu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Nintedanib induces senolytic effect via STAT3 inhibition
Hyun-Ji Cho, Jeong-A Hwang, Eun Jae Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 22
Developments in Genetics: Better Management of Ovarian Cancer Patients
Ovidiu Maioru, Viorica-Elena Rădoi, Madalin-Codrut Coman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15987-15987
Open Access | Times Cited: 15
Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling
Peter Kubatka, Lenka Koklesová, Alena Mazuráková, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 87-113
Open Access | Times Cited: 14
Head and neck cancer: pathogenesis and targeted therapy
Yan Liu, Nannan Zhang, Yi Wen, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 5
An In Silico Approach to Uncover Selective JAK1 Inhibitors for Breast Cancer from Life Chemicals Database
Sruthy Sathish, Honglae Sohn, Thirumurthy Madhavan
Applied Biochemistry and Biotechnology (2025)
Closed Access
Page 1 - Next Page

Scroll to top